logo
...
...

Contemporary Management of Acute Lymphoblastic Leukemia

VINOD PULLARKAT
ISBN: 978935152241620141/e

Synopsis

Acute lymphoblastic leukemia (ALL), the commonest childhood leukemia, is now an eminently curable disease in children, thanks to developments in chemotherapy over the last 6 decades. However, adult ALL still remains a therapeutic challenge, particularly in older patients who are not candidates for intensive chemotherapy or hematopoietic stem cell transplantation (HSCT). Much work, therefore, remains to be done in order to improve outcomes of adult patients as well as patients with relapsed disease. This book is an attempt to compile the latest advances in the understanding of the pathogenesis of ALL as well as various aspects of its treatment.
MRP
0
Inclusive of all taxes
Available In stockSold by Jaypee Books and Delivered by Jaypee.

    Synopsis

    Acute lymphoblastic leukemia (ALL), the commonest childhood leukemia, is now an eminently curable disease in children, thanks to developments in chemotherapy over the last 6 decades. However, adult ALL still remains a therapeutic challenge, particularly in older patients who are not candidates for intensive chemotherapy or hematopoietic stem cell transplantation (HSCT). Much work, therefore, remains to be done in order to improve outcomes of adult patients as well as patients with relapsed disease. This book is an attempt to compile the latest advances in the understanding of the pathogenesis of ALL as well as various aspects of its treatment.
    MRP
    0
    Inclusive of all taxes
    Available In stockSold by Jaypee Books and Delivered by Jaypee.

      Description

      Acute lymphoblastic leukemia (ALL), the commonest childhood leukemia, is now an eminently curable disease in children, thanks to developments in chemotherapy over the last 6 decades. However, adult ALL still remains a therapeutic challenge, particularly in older patients who are not candidates for intensive chemotherapy or hematopoietic stem cell transplantation (HSCT). Much work, therefore, remains to be done in order to improve outcomes of adult patients as well as patients with relapsed disease. This book is an attempt to compile the latest advances in the understanding of the pathogenesis of ALL as well as various aspects of its treatment.

      Permissions

      Request permissionto reuse content from this site

      Key Features

      • Comprehensive and up-to-date coverage of the epidemiology, molecular pathogenesis, and cytogenetics of ALL 

      • Extensive discussion of clinical trial data in childhood and adult ALL 

      • Chapters devoted to in-depth coverage of key aspects of therapy including use of asparaginase, treatment of central nervous system ALL, and management of long-term sequelae 

      • Detailed coverage of emerging areas including minimal residual disease monitoring and pharmacogenomics 

      • Discussion of novel therapies including bispecific T-cell engaging antibody therapy and chimeric antigen receptor expressing T-cell therapy.

      Product Details

      Publisher :

      JPB

      Edition :

      1/e

      Binding :

      Hard Back

      Language :

      English

      Pages :

      350

      ISBN-13 :

      9789351522416

      Item Weight :

      740 grams

      Dimensions :

      6.5 x 9

      Printing Format Color :

      Four Color

      Copyright year :

      2014